News
Amneal plans to launch the product in the third quarter of 2025. According to IQVIA, U.S. annual sales for prednisolone acetate ophthalmic suspension for the 12 months ended April 2025 were about ...
BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of ...
Key complex product approval in the Affordable Medicines segment this year Commercial launch planned for third quarter of 2025 BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal ...
AVI Systems today introduced itself as FORTÉ. The new company name, logo and brand identity positions the company as an industry leader in the delivery and support of communication and collaboration ...
After production of the Forte ceased in 2024, Kia wasted no time in transitioning to its successor, the all-new 2025 Kia K4 compact sedan. Like the outgone Forte, the K4 comes standard with a 2.0 ...
Forte succeeded in convincing Kilmer to try watching it, and soon he was hooked. “Then, at a certain point, he said, ‘Will, you and I have to go do “The Amazing Race.” We have to.
Tata Power, ONGC, PNC Infratech, KEI Industries, GR Infraprojects, Capri Global Capital, RailTel, Lupin, Adani Energy Solutions, CCI, Power Grid, Cochin Shipyard ...
Lupin launches first generic formulation of Abbie’s drug to treat eye disorder Pred Forte had estimated annual sales of USD 198 million in the U.S., as per IQVIA MAT August 2024.
Lupin introduces generic Pred Forte in United States Our Bureau, Mumbai Tuesday, October 15, 2024, 13:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced the launch of the first generic ...
Global pharma major Lupin Limited (Lupin) announced the launch of the first generic version of Pred Forte (prednisolone acetate) ophthalmic suspension USP, 1% in the United States. Being the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results